OrganOx
OrganOx is a medical technology company, based in Oxford, UK, that has developed metra, a revolutionary device for storing livers at normal body temperatures for extended periods of time, which is commercially available within the EU.
OrganOx was founded in 2008 to exploit technology invented by Professor Peter Friend and colleagues and further developed by Professor Constantin Coussios at the University of Oxford. The normothermic liver perfusion device that has been developed is transforming liver transplantation.
OrganOx is engaged in a further pivotal study in the US and a further study at the Queen Elizabeth Hospital, Birmingham to test the viability and transplant potential of marginal livers.
Amadeus contact
In the media
23rd September 2020
Global Organ Transplantation Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
Transonic OrganOX Limited Novartis International AG GlaxoSmithKline Plc. Accord Healthcare GmbH Pfizer, Inc. Astellas Pharma, Inc Preservation Solutions, Inc. Terumo Medical Corporation Veloxis Pharmaceuticals A/S F. Hoffmann-La Roche Ltd. TransMedic, Inc. Transplant Biomedical Bio Med Pvt. Ltd. In Chapter 11 and 13.3, on the basis
23rd September 2020
Global Organ Transplantation Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
Transonic OrganOX Limited Novartis International AG GlaxoSmithKline Plc. Accord Healthcare GmbH Pfizer, Inc. Astellas Pharma, Inc Preservation Solutions, Inc. Terumo Medical Corporation Veloxis Pharmaceuticals A/S F. Hoffmann-La Roche Ltd. TransMedic, Inc. Transplant Biomedical Bio Med Pvt. Ltd. In Chapter 11 and 13.3, on the basis
23rd September 2020
Global Organ Transplantation Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
Transonic OrganOX Limited Novartis International AG GlaxoSmithKline Plc. Accord Healthcare GmbH Pfizer, Inc. Astellas Pharma, Inc Preservation Solutions, Inc. Terumo Medical Corporation Veloxis Pharmaceuticals A/S F. Hoffmann-La Roche Ltd. TransMedic, Inc. Transplant Biomedical Bio Med Pvt. Ltd. In Chapter 11 and 13.3, on the basis